Prohibition Is Running Out of Voters

Pew’s May 26, 2026 report says only 11 percent of U.S. adults want marijuana illegal in all cases. Pot Culture Magazine examines what that means for cannabis legalization, federal marijuana law, employment testing, immigration policy, banking barriers, and the drug war machinery still protecting prohibition after the public moved on.

France Still Fears Legal Weed

France keeps extending medical cannabis access while politically resisting broader legalization. Pot Culture Magazine examines the country’s cautious framework, frozen patient access, regulatory delays, and the growing contradiction between public rhetoric and the reality of cannabis reform already unfolding inside France.

Britain’s Legal Weed Lockout

The United Kingdom legalized medical cannabis in 2018, but most patients still cannot access it through the NHS. Private clinics filled the gap, creating a two-tier system where legal medicine exists, but access depends on money, specialist approval, narrow guidance, and a regulatory structure now facing sharper scrutiny.

The Federal Hemp Blueprint That Isn’t

A proposed federal hemp framework is being sold as long overdue clarity for a chaotic market. But beneath the promise of order, the structure reveals rigid caps, unresolved enforcement questions, and a quiet shift of power away from states and smaller producers. We break down what the proposal does, what it avoids, and why the difference matters.

Reefer Report Card Vol. 31: The Retreat Becomes Routine

Reefer Report Card Vol. 31 examines a week where cannabis reform quietly retreated. Ballot rollbacks gained traction, federal action stalled, and patients remained unprotected. Legal weed stayed popular, but oversight weakened and accountability slipped. Another week where legalization survived while governance failed

Reefer Report Card Vol. 30: The Floor Starts to Give

Reefer Report Card Vol. 30 tracks a week where legalization stalled while rollback efforts gained ground. Ballot initiatives threatened regulated markets, federal reform stayed stalled, and patients were left navigating uncertainty. Demand remained strong, but oversight weakened. Another week where cannabis survived while governance quietly failed.

Create a website or blog at WordPress.com

Up ↑